Category: News

Local councils have been urged to review their beach safety measures after an Australian tech company’s device played a crucial role in the rescue of a drowning fisherman this week.

An Aussie biotech company that develops personalised therapies to treat cancer says it has reached “a promising point in its evolution”, accentuated by a positive June quarter.

Advice from the Great Depression was to hide your money inside your home, but this tactic has led one man into a great depression of his own after his wife unknowingly dumped his stash.

The economic ship is steady again after being rocked by macroeconomic waves since 2020, but with troubled waters still ahead, experienced fundie Lee laFraté has agreed to share his ‘charts’ for smoother sailing.

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Altor Capital’s Benjamin Harrison selected XPON Technologies as one of his favourite stocks, pointing to the company’s high-growth phase, growing…

Investing in biotech has become an increasingly attractive proposition for venture capitalists, but the sector can be hard to navigate – so we’ve enlisted one of Australia’s foremost experts in the field to share his thoughts for those in, or considering buying into, the sector.

Investing in biotech has become an increasingly attractive proposition for venture capitalists, but the sector can be hard to navigate – so we’ve enlisted one of Australia’s foremost experts in the field to share his thoughts for those in, or considering buying into, the sector.

Central banks around the world are embarking on a frenzy of rate hikes as they try to rein in inflation. The IMF says 75 central banks have raised interest rates in the past year, moving almost four times each on average – including Canada, which last Wednesday surprised global markets with a 100 basis-point increase, the largest by any G7 economy since 1998.

The global market for SaaS (software as a service) has been forecast to hit A$1 trillion in the next six years – and a number of Australian businesses are well-positioned to ride the wave.

With Ukraine and Russia producing 80% of global exports of sunflower seed oil, supplies have dwindled in recent months, leading to a cooking oil shortage and supermarket restrictions throughout Europe – but one German pub has found a solution.

Australian health and wellness brands company Wellnex Life will bring registered medicinal cannabis and hemp-based products to domestic and international markets, via a newly formed joint venture with OneLife Botanicals.

The US Food and Drug Administration has granted ‘orphan drug designation’ to PTX-100 for the treatment of peripheral T-cell lymphomas, paving the way for Prescient Therapeutics to lock in years of market exclusivity.